China, Sept. 15 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Clinical Study of Sequential Immunotherapy and Chemotherapy After Concurrent Chemoradiotherapy for Conversion Treatment in Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600132455
Registration Time: 2026/09/14
Type: Interventional study
Primary Sponsor: The First Affiliated Hospital of Soochow University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=331016
Published by HT Digital Content Services with permission from Health Daily Digest....